CANbridge Pharmaceuticals: Funding, Investors & Team (Sep 2026)
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
CANbridge Pharmaceuticals has raised $43.0M across 1 funding round on record, the most recent an undisclosed round of $43.0M announced in Dec 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CANbridge Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2020.
CANbridge Pharmaceuticals Funding Rounds
CANbridge Pharmaceuticals Founders and Leadership Team
Contact details for the CANbridge Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →CANbridge Pharmaceuticals Funding Compared to Other Biotechnology Startups
CANbridge Pharmaceuticals' latest round of $43.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CANbridge Pharmaceuticals in Biotechnology and Beijing
Companies Similar to CANbridge Pharmaceuticals
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
NewLine researches phage feed additives to prevent livestock infections.
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
CANbridge Pharmaceuticals Funding FAQs
What does CANbridge Pharmaceuticals do?
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
How much funding has CANbridge Pharmaceuticals raised?
CANbridge Pharmaceuticals has raised $43.0M across 1 round on record. The most recent is an undisclosed round of $43.0M announced in Dec 2020.
When did CANbridge Pharmaceuticals last raise funding?
CANbridge Pharmaceuticals' most recent funding round on record is an undisclosed round of $43.0M, announced in Dec 2020.
Who is the CEO of CANbridge Pharmaceuticals?
James Xue is listed as CEO at CANbridge Pharmaceuticals.
Where is CANbridge Pharmaceuticals headquartered?
CANbridge Pharmaceuticals is based in Beijing, China.
How many employees does CANbridge Pharmaceuticals have?
CANbridge Pharmaceuticals is in the 101-250 employee band.
How does CANbridge Pharmaceuticals' funding compare to other Biotechnology startups?
CANbridge Pharmaceuticals' latest round of $43.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's CANbridge Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CANbridge Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.